KALA BIO, INC. Restricted Cash, Current
KALA BIO, INC. (KALA) had Restricted Cash, Current of $450.00 thousand as of 2022-06-30, per its 10-Q filed 2022-08-11.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2023-03-03
- 2022-06-30: Restricted Cash, Current $450.00K.
- 2021-12-31: Restricted Cash, Current $2.04M.
| Period end | Restricted Cash, Current |
|---|---|
| 2022-06-30 | $450.00K 10-Q · filed 2022-08-11 |
| 2021-12-31 | $2.04M 10-K · filed 2023-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |